Common Contracts

2 similar Joint Development and License Agreement contracts by Pfenex Inc.

EX-10.6 10 d576774dex106.htm EX-10.6 CONFIDENTIAL EXECUTION COPY JOINT DEVELOPMENT & LICENSE AGREEMENT
Joint Development and License Agreement • May 5th, 2020 • England and Wales

This Joint Development and License Agreement (this “Agreement”) is made as of the 31st day of December 2012 (the “Effective Date”), by and between Pfenex, Inc., a Delaware corporation with a principal place of business located at 10790 Roselle Street, San Diego, CA 92121 (“Pfenex”), and Agila Biotech Private Limited, company incorporated under the Companies Act, 1956 and having its registered office at Strides House, Bilekahalli, Bannerghatta Road, Bangalore 560 076, India (“Agila”). Pfenex and Agila may be referred to individually as a “Party” or together as the “Parties.”

JOINT DEVELOPMENT & LICENSE AGREEMENT
Joint Development and License Agreement • May 5th, 2014 • Pfenex Inc. • Pharmaceutical preparations • England and Wales

This Joint Development and License Agreement (this “Agreement”) is made as of the 31st day of December 2012 (the “Effective Date”), by and between Pfenex, Inc., a Delaware corporation with a principal place of business located at 10790 Roselle Street, San Diego, CA 92121 (“Pfenex”), and Agila Biotech Private Limited, company incorporated under the Companies Act, 1956 and having its registered office at Strides House, Bilekahalli, Bannerghatta Road, Bangalore 560 076, India (“Agila”). Pfenex and Agila may be referred to individually as a “Party” or together as the “Parties.”